ArticlePloS one2025
Multi-dimensional analysis of the global burden of colorectal cancer disease from 1990 to 2021 and prediction of future trends: A comprehensive study based on the GBD database.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Serum metabolomics modelling reveals stage-associated purine and endocannabinoid metabolic signatures in colorectal cancer progression.Frontiers in oncology · 2026Article
- Development and validation of a predictive model for pathological upgrading in colorectal polyps based on endoscopic forceps biopsy.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundColorectal cancer (CRC) is one of the malignancies with high morbidity and mortality rates worldwide, and its disease burden continues to increase with population aging and changes in lifestyle and dietary habits. Based on the Global Burden of Disease database (GBD), this study analyzed trends in global CRC incidence, deaths, and disability-adjusted life years (DALYs) from 1990 to 2021, and explored health inequalities across countries and regions.
methodsThis study used data from the GBD Database 2021 to quantify the contribution of population aging, population growth, and epidemiological changes to the burden of CRC. Health inequalities were assessed on a global scale through the Slope index (SII) and concentration index (CI), and the potential room for improvement in the control of DALYs burden in CRC was assessed by countries using frontier analysis. The future disease burden of CRC was predicted based on a Bayesian Age-Period-cohort model (BAPC).
resultsWorldwide, the incidence, death and DALYs burden of CRC increased significantly, mainly driven by population aging and population growth. Areas with high socio-demographic index (SDI) have significantly reduced the burden of disease through epidemiological changes, while the burden remains higher in areas with low SDI. Health inequalities have improved, but areas with low SDI still face a higher burden of disease. Frontier analysis shows that there is still much room for improvement in CRC prevention and control in countries with high SDI. Projections show that despite the decline in CRC deaths, the number of cases of CRC is expected to continue to increase due to the impact of population aging and population growth.
conclusionsPopulation aging and growth drive the global CRC burden increase. Low - SDI regions' epidemiological changes have limited impact. Future policies should focus on low - SDI areas' early prevention and screening and optimize resource allocation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.